Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever

Clinical and Experimental Immunology

Volumn 111, Issue 3, 1998, Pages 555-558

  Mansueto, S ^a   Vitale, G ^a   Mocciaro, C ^a   Gambino, G ^a   Colletti, P ^b   Mansueto, P ^a   Spinelli, A ^a   Affronti, M ^a   Chifari, N ^a   Arcoleo, F ^b   Milano, S ^b   Cillari, E ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

2 microglobulin; sCD4; sCD8; sHLA I; T subsets in Boutonneuse fever

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1;

ADULT; AGED; ARTICLE; BOUTONNEUSE FEVER; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOLUTION; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RICKETTSIACEAE;

ADULT; AGED; ANTIGENS, CD4; ANTIGENS, CD8; BETA 2-MICROGLOBULIN; BOUTONNEUSE FEVER; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MIDDLE AGED; SOLUBILITY; T-LYMPHOCYTE SUBSETS;

EID: 6844260518     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00502.x     Document Type: Article

References (22)

1. Wolbach SB, Todd JL, Palfrey FW. Pathology of typhus in man. In: Wolbach SB, Todd JL, Palfrey FW, eds. The etiology and pathology of typhus. Cambridge, MA: League of Red Cross Societies at the Harvard University Press, 1922; 152-221.
2. Jerrels TR. Mechanisms of immunity to rickettsia species and Coxiella burnetii. In Walker DH, ed. Biology of rickettsial diseases. Boca Raton, FL: CRC Press, Inc. 1988:79-100.
3. Walker DH, Herrero-Herrero JI, Ruitz-Beltram R, Bullon-Sopelama A, Ramon-Hidalgo A. The pathology of fatal Mediterranean spotted fever. Am J Clin Pathol 1987; 87:669-72.
4. Cillari E, Milano S. D'Agostino P et al. Depression of CD4 T cell subsets and alteration in cytokine prolile in Boutonneuse fever. J Infect Dis 1996; 174:1051-7.
5. Oristrell J, Amengual MJ, Font-Creus B, Casanovas A, Segura-Porta F. Plasma levels of tumor necrosis factor-α in patients with spotted fever: clinical and analytical correlations. Clin Infect Dis 1994; 19:1141-3.
6. Mansueto S, D'Aneona FP, Colletti P et al. Alteration of interleukin-2 (IL-2) and soluble IL-2 receptor secretion in the sera and urine of patients with rickettsial Boutonneuse fever. J Infect Dis 1997; 175:142-5.
7. 2-microglobulin in visceral human leishmaniasis. Clin Exp Immunol 1994; 97:280-3.
8. Biglino A, Sinicco A, Forno B. et al. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol 1996; 78:61-69.
9. Symons JA, Wood NC, Digiovane FS, Duff GW. Soluble CD8 in patients with rheumatic disease. Clin Exp Immunol 1990; 80:354-60.
10. Zavazava N, Böttcher H, Müller-Ruchholtz W, Soluble MCH class I antigens (sHLAs) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993; 42:20-26.
11. 2-microglobulin as a marker of activity in systemic lupus erythematosus. Scand J Rheumatol 1986; 15:201-6.
12. Puppo F, Scudeletti M, Indiveri F, Ferrone S, Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 1995; 16:124-7.
13. Furukawa S, Matsubara T, Tsuji K et al. Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 1991; 86:134-9.
14. Fujimoto J, Levy S, Levy R, Spontaneous release of the leu-2 (T8) molecule from human T-cells. J Exp Med 1983; 159:752-8.
15. Gay D, Maddon P, Sekaly R et al. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 1987; 328:626-9.
16. Norment AM, Salter RD, Parham P, Engelhard VH, Littman DR. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 1988; 336:79-81.
17. Tomkinson BE, Brown MC, Ip SH et al. Soluble CD8 during T cell activation. J Immunol 1989; 42:2230-6.
18. Symons JA, McCulloch JF, Wood NC, Duff GW. Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol 1991; 60:72-82.
19. Herrero-Herrero JI, Walker DH, Ruitz-Beltran R. Immunohistochemical evaluation of the cellular immune response to Rickettsia conorii in Taches noires. J Infect Dis 1987; 155:802-5.
20. Aulitzky WE, Grosse-Wild H, Westhoff U et al. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-γ). Clin Exp Immunol 1991; 86:236-9.
21. Villar LM, Roy G, Lazaro I et al. Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture. Fur J Immunol 1989; 19:1835-9.
22. Zavazava N, Krönke M, Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 9:1005-10.